Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

Abstract Background Iron is required for cellular metabolism, and rapidly proliferating cancer cells require more of this essential nutrient. Therefore, iron regulation may well represent a new avenue for cancer therapy. We have reported, through in vitro and in vivo research involving pancreatic ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Shogo Amano, Seiji Kaino, Shuhei Shinoda, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, Isao Sakaida
Médium: Artigo
Jazyk:Inglês
Vydáno: BMC 2020-07-01
Edice:BMC Cancer
Témata:
Pancreatic cancer
Iron chelation
Cancer therapy
Rho family protein
Deferasirox
Invasion
On-line přístup:http://link.springer.com/article/10.1186/s12885-020-07167-8
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky